SCHEMBL23845075

SCHEMBL23845075

CCCCOc1cc(F)cc(CCCCCC(=O)CC(C)CC)c1

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 19/20 0.47
▸ CNR1 P21554 18/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29307145 0.82 CNR1 (0.47) CNR2CNR1
SCHEMBL27018353 0.77 CNR1 (0.47) CNR2CNR1
SCHEMBL25123387 0.74 CNR2 (0.45) CNR2CNR1
SCHEMBL14445682 0.71 FAAH (0.43) —
SCHEMBL22525342 0.71 FFAR4 (0.40) CNR2CNR1
SCHEMBL14406001 0.70 KMT2A (0.52) —
SCHEMBL16956782 0.69 CYP4F2 (0.54) CNR2CNR1
SCHEMBL18591909 0.69 LMNA (0.61) —
SCHEMBL20838321 0.68 KMT2A (0.48) —
SCHEMBL26206484 0.68 FFAR4 (0.37) CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021188696-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-09-23 — — WO disclosed
Send feedback